SUVmax (maximum standardized uptake value) may provide a marker to indicate progression-free survival in Stage 1 nonsmall cell lung cancer patients treated with radiation therapy, according to research presented Feb. 9 at the 2013 Cancer Imaging and Radiation Therapy Symposium in Orlando, Fla.

GE Healthcare announced two new image analysis software packages for cardiovascular MR images: CardiacVX and MR VesselIQ Xpress

While myocardial perfusion imaging using cadmium-zinc-telluride (CZT) SPECT cameras accurately measures left ventricular ejection fraction, the method underestimates left ventricular volumes, according to a study published online Feb. 5 in the Journal of Nuclear Medicine.

Semiquantitative analysis of dual-time-point FDG PET data increased specificity for pediatric malignancies compared with single-time-point PET imaging, according to a study published in the February issue of American Journal of Roentgenology.

Flurpiridaz F-18 PET myocardial perfusion imaging (MPI) outperformed SPECT MPI in terms of image quality, diagnostic certainty and sensitivity, according to a study published Jan. 22 in the Journal of the American College of Cardiology.

The first human study of the cell proliferation marker F18-ISO-1 indicated its safety and feasibility and suggested it may be used to stratify patients into high and low Ki-67 proliferative groups. The study was published online Jan. 28 in The Journal of Nuclear Medicine.

Resting cardiac CT performed on a 64-slice system does not reliably detect myocardial ischemia compared with radionuclide myocardial perfusion imaging (MPI), according to a study published in the February issue of the American Journal of Roentgenology.

Lantheus Medical Imaging has appointed Jeffrey A. Bailey as its president, CEO and a member of the board of directors, and Brian A. Markison as chairman of the board.